Rectal Cancer Clinical Trials in Shanghai, Shanghai Municipality
34 recruitingShanghai, Shanghai Municipality, China
Showing 1–20 of 34 trials
Recruiting
Phase 2Phase 3
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Untreated, Unresectable, or Metastatic Colorectal Cancer
Bristol-Myers Squibb990 enrolled263 locationsNCT07221357
Recruiting
Not Applicable
The Impact of Probiotic Intervention on the Gut Microbiota and Bowel Function
Rectal Cancer
Huashan Hospital156 enrolled1 locationNCT07369830
Recruiting
Phase 1Phase 2
TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal Cancer
RAS/BRAF Wild Type Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.72 enrolled27 locationsNCT07044908
Recruiting
Phase 2
Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal Cancer
Metastatic Colorectal Cancer (CRC)
Fudan University119 enrolled1 locationNCT06856187
Recruiting
Phase 2
A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
Advanced Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd.60 enrolled2 locationsNCT06885385
Recruiting
Phase 1
A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor
Shanghai Junshi Bioscience Co., Ltd.214 enrolled13 locationsNCT06839105
Recruiting
Not Applicable
Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
Rectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1,384 enrolled8 locationsNCT06146946
Recruiting
Phase 2
Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer
Colorectal Cancer Metastatic
Fudan University36 enrolled1 locationNCT06763029
Recruiting
Phase 2
Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis
Liver MetastasesColorectal Cancer Metastatic
Fudan University25 enrolled1 locationNCT05057052
Recruiting
The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)
Advanced Colorectal Cancer
Ruijin Hospital30 enrolled1 locationNCT06601075
Recruiting
Phase 2
A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
Metastatic Colorectal Cancer
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.130 enrolled1 locationNCT06493760
Recruiting
Phase 2
Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer
Microsatellite Stable Metastatic Colorectal Cancer
Fudan University96 enrolled1 locationNCT06525428
Recruiting
Early Phase 1
Chemokine and Co-stimulatory Molecule-modified Mesenchymal Stem Cells for the Treatment of Advanced Colorectal Cancer
Advanced Colorectal Cancer
Shanghai East Hospital30 enrolled1 locationNCT06446050
Recruiting
Phase 3
Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer
High-risk Stage II Colorectal CancerStage III Colorectal CancerCirculating Tumor DNA Methylation
Fudan University340 enrolled1 locationNCT05954078
Recruiting
Phase 1
Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Shanghai Zhongshan Hospital78 enrolled1 locationNCT06225622
Recruiting
Phase 1Phase 2
Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy
Neoadjuvant TreatmentRectal CancerRadiotherapy+1 more
Shanghai Minimally Invasive Surgery Center20 enrolled1 locationNCT05111860
Recruiting
Phase 3
Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC
Metastatic Microsatellite-stable Colorectal Cancer
Sun Yat-sen University176 enrolled12 locationsNCT05768503
Recruiting
Phase 2
Organ Preservation Strategy of Total Neoadjuvant Chemoradiotherapy for Low Rectal Carcinoma
Rectal Cancer
Shanghai Zhongshan Hospital56 enrolled1 locationNCT05563922
Recruiting
Phase 3
Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer
Rectal Cancer
Fudan University300 enrolled1 locationNCT05201430
Recruiting
Phase 3
Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer
Stage III Colorectal CancerStage II Colorectal Cancer
Fudan University2,500 enrolled1 locationNCT05086614